nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—S100A4—brain cancer	0.556	1	CbGaD
Trifluoperazine—XDH—Procarbazine—brain cancer	0.22	0.722	CbGbCtD
Trifluoperazine—XDH—Carboplatin—brain cancer	0.0538	0.177	CbGbCtD
Trifluoperazine—CYP1A2—Carmustine—brain cancer	0.0198	0.0652	CbGbCtD
Trifluoperazine—CYP1A2—Etoposide—brain cancer	0.00588	0.0193	CbGbCtD
Trifluoperazine—ABCB1—Etoposide—brain cancer	0.00514	0.0169	CbGbCtD
Trifluoperazine—HTR2C—choroid plexus—brain cancer	0.00375	0.0607	CbGeAlD
Trifluoperazine—Edema cerebral—Carmustine—brain cancer	0.00269	0.0592	CcSEcCtD
Trifluoperazine—Edema cerebral—Temozolomide—brain cancer	0.0026	0.0572	CcSEcCtD
Trifluoperazine—HTR2A—choroid plexus—brain cancer	0.00188	0.0304	CbGeAlD
Trifluoperazine—CALM1—trigeminal nerve—brain cancer	0.00156	0.0253	CbGeAlD
Trifluoperazine—Brain oedema—Carmustine—brain cancer	0.00145	0.032	CcSEcCtD
Trifluoperazine—HRH1—nose—brain cancer	0.00145	0.0235	CbGeAlD
Trifluoperazine—Brain oedema—Temozolomide—brain cancer	0.00141	0.0309	CcSEcCtD
Trifluoperazine—Pigmentation disorder—Temozolomide—brain cancer	0.0012	0.0265	CcSEcCtD
Trifluoperazine—HTR6—ganglion—brain cancer	0.00118	0.0191	CbGeAlD
Trifluoperazine—CALM1—cranial nerve—brain cancer	0.00111	0.018	CbGeAlD
Trifluoperazine—CALM2—pons—brain cancer	0.0011	0.0179	CbGeAlD
Trifluoperazine—CALM1—pons—brain cancer	0.0011	0.0178	CbGeAlD
Trifluoperazine—HTR2C—telencephalic ventricle—brain cancer	0.0011	0.0178	CbGeAlD
Trifluoperazine—Pigmentation disorder—Etoposide—brain cancer	0.000963	0.0212	CcSEcCtD
Trifluoperazine—HTR2A—trigeminal nerve—brain cancer	0.000951	0.0154	CbGeAlD
Trifluoperazine—HTR2A—cerebellar cortex—brain cancer	0.000947	0.0153	CbGeAlD
Trifluoperazine—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.000928	0.0204	CcSEcCtD
Trifluoperazine—HTR1A—telencephalic ventricle—brain cancer	0.000924	0.015	CbGeAlD
Trifluoperazine—CALY—telencephalon—brain cancer	0.000878	0.0142	CbGeAlD
Trifluoperazine—HTR2A—vein—brain cancer	0.000859	0.0139	CbGeAlD
Trifluoperazine—DRD2—telencephalic ventricle—brain cancer	0.000835	0.0135	CbGeAlD
Trifluoperazine—CALM2—pineal body—brain cancer	0.000788	0.0128	CbGeAlD
Trifluoperazine—CALM1—pineal body—brain cancer	0.000785	0.0127	CbGeAlD
Trifluoperazine—Amenorrhoea—Procarbazine—brain cancer	0.000756	0.0166	CcSEcCtD
Trifluoperazine—CALY—pituitary gland—brain cancer	0.000715	0.0116	CbGeAlD
Trifluoperazine—CALY—medulla oblongata—brain cancer	0.00069	0.0112	CbGeAlD
Trifluoperazine—HTR2C—ganglion—brain cancer	0.000684	0.0111	CbGeAlD
Trifluoperazine—HTR2A—cranial nerve—brain cancer	0.000678	0.011	CbGeAlD
Trifluoperazine—HTR2A—pons—brain cancer	0.000669	0.0108	CbGeAlD
Trifluoperazine—Throat tightness—Etoposide—brain cancer	0.000655	0.0144	CcSEcCtD
Trifluoperazine—CALY—midbrain—brain cancer	0.00063	0.0102	CbGeAlD
Trifluoperazine—Pancytopenia—Lomustine—brain cancer	0.000623	0.0137	CcSEcCtD
Trifluoperazine—S100A4—pituitary gland—brain cancer	0.000617	0.00999	CbGeAlD
Trifluoperazine—CALY—spinal cord—brain cancer	0.000615	0.00995	CbGeAlD
Trifluoperazine—EBPL—endocrine gland—brain cancer	0.000605	0.0098	CbGeAlD
Trifluoperazine—EBPL—head—brain cancer	0.000598	0.00967	CbGeAlD
Trifluoperazine—S100A4—medulla oblongata—brain cancer	0.000595	0.00964	CbGeAlD
Trifluoperazine—Gynaecomastia—Procarbazine—brain cancer	0.000594	0.0131	CcSEcCtD
Trifluoperazine—Amenorrhoea—Hydroxyurea—brain cancer	0.000585	0.0129	CcSEcCtD
Trifluoperazine—EBP—endocrine gland—brain cancer	0.00058	0.00939	CbGeAlD
Trifluoperazine—HTR1A—ganglion—brain cancer	0.000575	0.00931	CbGeAlD
Trifluoperazine—CALM2—ganglion—brain cancer	0.000566	0.00915	CbGeAlD
Trifluoperazine—CALM1—ganglion—brain cancer	0.000563	0.00911	CbGeAlD
Trifluoperazine—CALY—endocrine gland—brain cancer	0.000554	0.00896	CbGeAlD
Trifluoperazine—HTR2A—telencephalic ventricle—brain cancer	0.000551	0.00891	CbGeAlD
Trifluoperazine—Photosensitivity—Procarbazine—brain cancer	0.000549	0.0121	CcSEcCtD
Trifluoperazine—CALY—head—brain cancer	0.000547	0.00885	CbGeAlD
Trifluoperazine—EBPL—central nervous system—brain cancer	0.000546	0.00883	CbGeAlD
Trifluoperazine—S100A4—midbrain—brain cancer	0.000544	0.00881	CbGeAlD
Trifluoperazine—Haemolytic anaemia—Procarbazine—brain cancer	0.000534	0.0118	CcSEcCtD
Trifluoperazine—EBPL—cerebellum—brain cancer	0.000533	0.00863	CbGeAlD
Trifluoperazine—Extrapyramidal disorder—Temozolomide—brain cancer	0.000533	0.0117	CcSEcCtD
Trifluoperazine—S100A4—spinal cord—brain cancer	0.000531	0.00859	CbGeAlD
Trifluoperazine—Cholestasis—Temozolomide—brain cancer	0.000529	0.0116	CcSEcCtD
Trifluoperazine—DRD2—ganglion—brain cancer	0.00052	0.00841	CbGeAlD
Trifluoperazine—TNNC1—pituitary gland—brain cancer	0.000519	0.0084	CbGeAlD
Trifluoperazine—CALY—central nervous system—brain cancer	0.000499	0.00807	CbGeAlD
Trifluoperazine—CALY—cerebellum—brain cancer	0.000488	0.00789	CbGeAlD
Trifluoperazine—CALM2—endothelium—brain cancer	0.000488	0.00789	CbGeAlD
Trifluoperazine—CALM1—endothelium—brain cancer	0.000485	0.00785	CbGeAlD
Trifluoperazine—S100A4—endocrine gland—brain cancer	0.000478	0.00774	CbGeAlD
Trifluoperazine—HTR2A—pineal body—brain cancer	0.000478	0.00773	CbGeAlD
Trifluoperazine—Liver injury—Temozolomide—brain cancer	0.000477	0.0105	CcSEcCtD
Trifluoperazine—S100A4—head—brain cancer	0.000472	0.00764	CbGeAlD
Trifluoperazine—Amenorrhoea—Temozolomide—brain cancer	0.000457	0.0101	CcSEcCtD
Trifluoperazine—HTR6—telencephalon—brain cancer	0.000456	0.00738	CbGeAlD
Trifluoperazine—CALM2—blood vessel—brain cancer	0.00045	0.00728	CbGeAlD
Trifluoperazine—CALM1—blood vessel—brain cancer	0.000448	0.00724	CbGeAlD
Trifluoperazine—HTR1A—hindbrain—brain cancer	0.000436	0.00706	CbGeAlD
Trifluoperazine—EBPL—brain—brain cancer	0.000433	0.00701	CbGeAlD
Trifluoperazine—CALM2—hindbrain—brain cancer	0.000429	0.00694	CbGeAlD
Trifluoperazine—CALM1—hindbrain—brain cancer	0.000427	0.00691	CbGeAlD
Trifluoperazine—Gait disturbance—Carmustine—brain cancer	0.000426	0.00938	CcSEcCtD
Trifluoperazine—S100A4—cerebellum—brain cancer	0.000421	0.00681	CbGeAlD
Trifluoperazine—UGT1A4—endocrine gland—brain cancer	0.00042	0.00679	CbGeAlD
Trifluoperazine—Dysphagia—Procarbazine—brain cancer	0.000417	0.00918	CcSEcCtD
Trifluoperazine—Eosinophilia—Procarbazine—brain cancer	0.000413	0.00909	CcSEcCtD
Trifluoperazine—Gait disturbance—Temozolomide—brain cancer	0.000411	0.00906	CcSEcCtD
Trifluoperazine—Leukopenia—Lomustine—brain cancer	0.000409	0.00901	CcSEcCtD
Trifluoperazine—ADRA1A—hindbrain—brain cancer	0.000402	0.00651	CbGeAlD
Trifluoperazine—CALY—brain—brain cancer	0.000396	0.00641	CbGeAlD
Trifluoperazine—Pancytopenia—Procarbazine—brain cancer	0.000396	0.00871	CcSEcCtD
Trifluoperazine—DRD2—hindbrain—brain cancer	0.000394	0.00638	CbGeAlD
Trifluoperazine—Photosensitivity reaction—Procarbazine—brain cancer	0.00038	0.00838	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Temozolomide—brain cancer	0.000377	0.0083	CcSEcCtD
Trifluoperazine—Gynaecomastia—Carmustine—brain cancer	0.000372	0.00819	CcSEcCtD
Trifluoperazine—Drowsiness—Procarbazine—brain cancer	0.000371	0.00818	CcSEcCtD
Trifluoperazine—Jaundice—Procarbazine—brain cancer	0.000362	0.00798	CcSEcCtD
Trifluoperazine—Anorexia—Lomustine—brain cancer	0.000356	0.00783	CcSEcCtD
Trifluoperazine—HTR2A—ganglion—brain cancer	0.000343	0.00555	CbGeAlD
Trifluoperazine—S100A4—brain—brain cancer	0.000342	0.00553	CbGeAlD
Trifluoperazine—Body temperature increased—Carboplatin—brain cancer	0.000337	0.00743	CcSEcCtD
Trifluoperazine—Decreased appetite—Lomustine—brain cancer	0.000324	0.00715	CcSEcCtD
Trifluoperazine—Nasal congestion—Temozolomide—brain cancer	0.00032	0.00705	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Temozolomide—brain cancer	0.000309	0.0068	CcSEcCtD
Trifluoperazine—Pancytopenia—Hydroxyurea—brain cancer	0.000306	0.00674	CcSEcCtD
Trifluoperazine—XDH—endocrine gland—brain cancer	0.000306	0.00495	CbGeAlD
Trifluoperazine—HTR2C—brainstem—brain cancer	0.000297	0.00481	CbGeAlD
Trifluoperazine—HTR2A—endothelium—brain cancer	0.000296	0.00478	CbGeAlD
Trifluoperazine—Body temperature increased—Lomustine—brain cancer	0.000295	0.0065	CcSEcCtD
Trifluoperazine—Weight increased—Hydroxyurea—brain cancer	0.000293	0.00646	CcSEcCtD
Trifluoperazine—Drowsiness—Hydroxyurea—brain cancer	0.000288	0.00633	CcSEcCtD
Trifluoperazine—HTR6—head—brain cancer	0.000284	0.0046	CbGeAlD
Trifluoperazine—Nervousness—Procarbazine—brain cancer	0.000282	0.00621	CcSEcCtD
Trifluoperazine—CALM3—telencephalon—brain cancer	0.000278	0.0045	CbGeAlD
Trifluoperazine—CHRM2—telencephalon—brain cancer	0.000274	0.00443	CbGeAlD
Trifluoperazine—HTR2A—blood vessel—brain cancer	0.000273	0.00441	CbGeAlD
Trifluoperazine—Tremor—Procarbazine—brain cancer	0.000272	0.00599	CcSEcCtD
Trifluoperazine—Muscular weakness—Carmustine—brain cancer	0.000266	0.00586	CcSEcCtD
Trifluoperazine—HTR2C—telencephalon—brain cancer	0.000264	0.00427	CbGeAlD
Trifluoperazine—Dysphagia—Carmustine—brain cancer	0.000261	0.00574	CcSEcCtD
Trifluoperazine—HTR2A—hindbrain—brain cancer	0.00026	0.00421	CbGeAlD
Trifluoperazine—Leukopenia—Procarbazine—brain cancer	0.00026	0.00572	CcSEcCtD
Trifluoperazine—HTR6—central nervous system—brain cancer	0.000259	0.0042	CbGeAlD
Trifluoperazine—Muscular weakness—Temozolomide—brain cancer	0.000257	0.00566	CcSEcCtD
Trifluoperazine—Cough—Procarbazine—brain cancer	0.000253	0.00558	CcSEcCtD
Trifluoperazine—Dysphagia—Temozolomide—brain cancer	0.000252	0.00555	CcSEcCtD
Trifluoperazine—Convulsion—Procarbazine—brain cancer	0.000252	0.00554	CcSEcCtD
Trifluoperazine—HTR1A—brainstem—brain cancer	0.00025	0.00405	CbGeAlD
Trifluoperazine—SIGMAR1—telencephalon—brain cancer	0.000248	0.00402	CbGeAlD
Trifluoperazine—Pancytopenia—Carmustine—brain cancer	0.000248	0.00545	CcSEcCtD
Trifluoperazine—CALM2—brainstem—brain cancer	0.000246	0.00398	CbGeAlD
Trifluoperazine—CALM1—brainstem—brain cancer	0.000245	0.00396	CbGeAlD
Trifluoperazine—Dry mouth—Procarbazine—brain cancer	0.000242	0.00532	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Etoposide—brain cancer	0.000241	0.00531	CcSEcCtD
Trifluoperazine—Pancytopenia—Temozolomide—brain cancer	0.000239	0.00527	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Carmustine—brain cancer	0.000235	0.00518	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Temozolomide—brain cancer	0.000232	0.00511	CcSEcCtD
Trifluoperazine—ADRA1A—brainstem—brain cancer	0.000231	0.00373	CbGeAlD
Trifluoperazine—Photosensitivity reaction—Temozolomide—brain cancer	0.00023	0.00506	CcSEcCtD
Trifluoperazine—Weight increased—Temozolomide—brain cancer	0.000229	0.00505	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Temozolomide—brain cancer	0.000227	0.005	CcSEcCtD
Trifluoperazine—CALM3—pituitary gland—brain cancer	0.000226	0.00366	CbGeAlD
Trifluoperazine—DRD2—brainstem—brain cancer	0.000226	0.00366	CbGeAlD
Trifluoperazine—Anorexia—Procarbazine—brain cancer	0.000226	0.00497	CcSEcCtD
Trifluoperazine—Erythema—Hydroxyurea—brain cancer	0.000225	0.00495	CcSEcCtD
Trifluoperazine—HTR1A—telencephalon—brain cancer	0.000222	0.00359	CbGeAlD
Trifluoperazine—Cardiac arrest—Etoposide—brain cancer	0.000222	0.00488	CcSEcCtD
Trifluoperazine—Nausea—Lomustine—brain cancer	0.000222	0.00488	CcSEcCtD
Trifluoperazine—Hypotension—Procarbazine—brain cancer	0.000221	0.00488	CcSEcCtD
Trifluoperazine—CALM3—medulla oblongata—brain cancer	0.000218	0.00353	CbGeAlD
Trifluoperazine—CALM2—telencephalon—brain cancer	0.000218	0.00353	CbGeAlD
Trifluoperazine—CALM1—telencephalon—brain cancer	0.000217	0.00351	CbGeAlD
Trifluoperazine—Insomnia—Procarbazine—brain cancer	0.000214	0.00472	CcSEcCtD
Trifluoperazine—Somnolence—Procarbazine—brain cancer	0.000211	0.00464	CcSEcCtD
Trifluoperazine—HTR2C—medulla oblongata—brain cancer	0.000207	0.00335	CbGeAlD
Trifluoperazine—Decreased appetite—Procarbazine—brain cancer	0.000206	0.00454	CcSEcCtD
Trifluoperazine—HTR6—brain—brain cancer	0.000206	0.00333	CbGeAlD
Trifluoperazine—Oedema peripheral—Carmustine—brain cancer	0.000206	0.00453	CcSEcCtD
Trifluoperazine—ADRA1A—telencephalon—brain cancer	0.000205	0.00331	CbGeAlD
Trifluoperazine—Fatigue—Procarbazine—brain cancer	0.000204	0.0045	CcSEcCtD
Trifluoperazine—Constipation—Procarbazine—brain cancer	0.000203	0.00446	CcSEcCtD
Trifluoperazine—SIGMAR1—pituitary gland—brain cancer	0.000202	0.00327	CbGeAlD
Trifluoperazine—Dysphagia—Etoposide—brain cancer	0.000202	0.00444	CcSEcCtD
Trifluoperazine—Leukopenia—Hydroxyurea—brain cancer	0.000201	0.00443	CcSEcCtD
Trifluoperazine—DRD2—telencephalon—brain cancer	0.000201	0.00325	CbGeAlD
Trifluoperazine—CALM3—midbrain—brain cancer	0.000199	0.00323	CbGeAlD
Trifluoperazine—Oedema peripheral—Temozolomide—brain cancer	0.000199	0.00437	CcSEcCtD
Trifluoperazine—Bronchospasm—Etoposide—brain cancer	0.000198	0.00437	CcSEcCtD
Trifluoperazine—SIGMAR1—medulla oblongata—brain cancer	0.000195	0.00316	CbGeAlD
Trifluoperazine—Convulsion—Hydroxyurea—brain cancer	0.000195	0.00429	CcSEcCtD
Trifluoperazine—CALM3—spinal cord—brain cancer	0.000195	0.00315	CbGeAlD
Trifluoperazine—Pancytopenia—Etoposide—brain cancer	0.000191	0.00422	CcSEcCtD
Trifluoperazine—HTR2C—midbrain—brain cancer	0.000189	0.00306	CbGeAlD
Trifluoperazine—Urticaria—Procarbazine—brain cancer	0.000188	0.00415	CcSEcCtD
Trifluoperazine—Body temperature increased—Procarbazine—brain cancer	0.000187	0.00413	CcSEcCtD
Trifluoperazine—HTR2C—spinal cord—brain cancer	0.000185	0.00299	CbGeAlD
Trifluoperazine—CALM2—gonad—brain cancer	0.000182	0.00295	CbGeAlD
Trifluoperazine—Erythema—Carmustine—brain cancer	0.000182	0.004	CcSEcCtD
Trifluoperazine—CALM1—gonad—brain cancer	0.000181	0.00293	CbGeAlD
Trifluoperazine—ABCB1—blood vessel—brain cancer	0.000179	0.00289	CbGeAlD
Trifluoperazine—SIGMAR1—midbrain—brain cancer	0.000178	0.00289	CbGeAlD
Trifluoperazine—Skin disorder—Hydroxyurea—brain cancer	0.000178	0.00392	CcSEcCtD
Trifluoperazine—CALM2—pituitary gland—brain cancer	0.000178	0.00287	CbGeAlD
Trifluoperazine—CALM1—pituitary gland—brain cancer	0.000177	0.00286	CbGeAlD
Trifluoperazine—Erythema—Temozolomide—brain cancer	0.000176	0.00387	CcSEcCtD
Trifluoperazine—Jaundice—Etoposide—brain cancer	0.000175	0.00386	CcSEcCtD
Trifluoperazine—Anorexia—Hydroxyurea—brain cancer	0.000175	0.00385	CcSEcCtD
Trifluoperazine—Hypersensitivity—Procarbazine—brain cancer	0.000175	0.00384	CcSEcCtD
Trifluoperazine—SIGMAR1—spinal cord—brain cancer	0.000174	0.00282	CbGeAlD
Trifluoperazine—CHRM2—endocrine gland—brain cancer	0.000173	0.00279	CbGeAlD
Trifluoperazine—CALM2—medulla oblongata—brain cancer	0.000171	0.00277	CbGeAlD
Trifluoperazine—Vision blurred—Carmustine—brain cancer	0.000171	0.00377	CcSEcCtD
Trifluoperazine—CALM1—medulla oblongata—brain cancer	0.000171	0.00276	CbGeAlD
Trifluoperazine—CHRM2—head—brain cancer	0.00017	0.00276	CbGeAlD
Trifluoperazine—Tremor—Carmustine—brain cancer	0.00017	0.00375	CcSEcCtD
Trifluoperazine—Asthenia—Procarbazine—brain cancer	0.00017	0.00374	CcSEcCtD
Trifluoperazine—Agranulocytosis—Etoposide—brain cancer	0.000168	0.00369	CcSEcCtD
Trifluoperazine—Pruritus—Procarbazine—brain cancer	0.000168	0.00369	CcSEcCtD
Trifluoperazine—Agitation—Carmustine—brain cancer	0.000167	0.00368	CcSEcCtD
Trifluoperazine—Vision blurred—Temozolomide—brain cancer	0.000165	0.00364	CcSEcCtD
Trifluoperazine—Tremor—Temozolomide—brain cancer	0.000164	0.00362	CcSEcCtD
Trifluoperazine—HTR2C—head—brain cancer	0.000164	0.00266	CbGeAlD
Trifluoperazine—Dyspnoea—Hydroxyurea—brain cancer	0.000163	0.0036	CcSEcCtD
Trifluoperazine—DRD2—pituitary gland—brain cancer	0.000163	0.00264	CbGeAlD
Trifluoperazine—Somnolence—Hydroxyurea—brain cancer	0.000163	0.00359	CcSEcCtD
Trifluoperazine—Leukopenia—Carmustine—brain cancer	0.000163	0.00358	CcSEcCtD
Trifluoperazine—Agitation—Temozolomide—brain cancer	0.000161	0.00355	CcSEcCtD
Trifluoperazine—Angioedema—Temozolomide—brain cancer	0.00016	0.00353	CcSEcCtD
Trifluoperazine—HTR1A—midbrain—brain cancer	0.000159	0.00258	CbGeAlD
Trifluoperazine—Decreased appetite—Hydroxyurea—brain cancer	0.000159	0.00351	CcSEcCtD
Trifluoperazine—HRH1—telencephalon—brain cancer	0.000158	0.00256	CbGeAlD
Trifluoperazine—Fatigue—Hydroxyurea—brain cancer	0.000158	0.00348	CcSEcCtD
Trifluoperazine—Convulsion—Carmustine—brain cancer	0.000157	0.00347	CcSEcCtD
Trifluoperazine—Leukopenia—Temozolomide—brain cancer	0.000157	0.00346	CcSEcCtD
Trifluoperazine—Constipation—Hydroxyurea—brain cancer	0.000157	0.00345	CcSEcCtD
Trifluoperazine—Dizziness—Procarbazine—brain cancer	0.000157	0.00345	CcSEcCtD
Trifluoperazine—CALM2—midbrain—brain cancer	0.000157	0.00254	CbGeAlD
Trifluoperazine—CALM1—midbrain—brain cancer	0.000156	0.00252	CbGeAlD
Trifluoperazine—HTR1A—spinal cord—brain cancer	0.000156	0.00252	CbGeAlD
Trifluoperazine—CHRM2—central nervous system—brain cancer	0.000156	0.00252	CbGeAlD
Trifluoperazine—CALM3—cerebellum—brain cancer	0.000154	0.0025	CbGeAlD
Trifluoperazine—Cough—Temozolomide—brain cancer	0.000153	0.00337	CcSEcCtD
Trifluoperazine—CALM2—spinal cord—brain cancer	0.000153	0.00247	CbGeAlD
Trifluoperazine—CALM1—spinal cord—brain cancer	0.000152	0.00246	CbGeAlD
Trifluoperazine—Convulsion—Temozolomide—brain cancer	0.000152	0.00335	CcSEcCtD
Trifluoperazine—HTR2C—central nervous system—brain cancer	0.00015	0.00243	CbGeAlD
Trifluoperazine—Rash—Procarbazine—brain cancer	0.000149	0.00329	CcSEcCtD
Trifluoperazine—Dermatitis—Procarbazine—brain cancer	0.000149	0.00329	CcSEcCtD
Trifluoperazine—HTR2A—brainstem—brain cancer	0.000149	0.00241	CbGeAlD
Trifluoperazine—Headache—Procarbazine—brain cancer	0.000148	0.00327	CcSEcCtD
Trifluoperazine—Dry mouth—Temozolomide—brain cancer	0.000146	0.00322	CcSEcCtD
Trifluoperazine—Body temperature increased—Hydroxyurea—brain cancer	0.000145	0.00319	CcSEcCtD
Trifluoperazine—DRD2—midbrain—brain cancer	0.000144	0.00233	CbGeAlD
Trifluoperazine—Anaphylactic shock—Temozolomide—brain cancer	0.000143	0.00316	CcSEcCtD
Trifluoperazine—Anorexia—Carmustine—brain cancer	0.000141	0.00311	CcSEcCtD
Trifluoperazine—Nausea—Procarbazine—brain cancer	0.000141	0.0031	CcSEcCtD
Trifluoperazine—HTR1A—endocrine gland—brain cancer	0.00014	0.00227	CbGeAlD
Trifluoperazine—Skin disorder—Temozolomide—brain cancer	0.000139	0.00306	CcSEcCtD
Trifluoperazine—Hypotension—Carmustine—brain cancer	0.000139	0.00305	CcSEcCtD
Trifluoperazine—HTR1A—head—brain cancer	0.000138	0.00224	CbGeAlD
Trifluoperazine—SIGMAR1—cerebellum—brain cancer	0.000138	0.00223	CbGeAlD
Trifluoperazine—CALM2—endocrine gland—brain cancer	0.000138	0.00223	CbGeAlD
Trifluoperazine—CALM1—endocrine gland—brain cancer	0.000137	0.00222	CbGeAlD
Trifluoperazine—Anorexia—Temozolomide—brain cancer	0.000137	0.00301	CcSEcCtD
Trifluoperazine—CALM2—head—brain cancer	0.000136	0.0022	CbGeAlD
Trifluoperazine—CALM1—head—brain cancer	0.000135	0.00219	CbGeAlD
Trifluoperazine—Hypersensitivity—Hydroxyurea—brain cancer	0.000135	0.00298	CcSEcCtD
Trifluoperazine—Muscle spasms—Etoposide—brain cancer	0.000135	0.00297	CcSEcCtD
Trifluoperazine—Insomnia—Carmustine—brain cancer	0.000134	0.00295	CcSEcCtD
Trifluoperazine—HTR2A—telencephalon—brain cancer	0.000132	0.00214	CbGeAlD
Trifluoperazine—Dyspnoea—Carmustine—brain cancer	0.000132	0.00291	CcSEcCtD
Trifluoperazine—Somnolence—Carmustine—brain cancer	0.000132	0.0029	CcSEcCtD
Trifluoperazine—Asthenia—Hydroxyurea—brain cancer	0.000132	0.0029	CcSEcCtD
Trifluoperazine—Insomnia—Temozolomide—brain cancer	0.00013	0.00285	CcSEcCtD
Trifluoperazine—ADRA1A—endocrine gland—brain cancer	0.000129	0.00209	CbGeAlD
Trifluoperazine—Decreased appetite—Carmustine—brain cancer	0.000129	0.00284	CcSEcCtD
Trifluoperazine—Dyspnoea—Temozolomide—brain cancer	0.000128	0.00281	CcSEcCtD
Trifluoperazine—ADRA1A—head—brain cancer	0.000127	0.00206	CbGeAlD
Trifluoperazine—Somnolence—Temozolomide—brain cancer	0.000127	0.0028	CcSEcCtD
Trifluoperazine—Constipation—Carmustine—brain cancer	0.000127	0.00279	CcSEcCtD
Trifluoperazine—DRD2—endocrine gland—brain cancer	0.000127	0.00205	CbGeAlD
Trifluoperazine—HTR1A—central nervous system—brain cancer	0.000126	0.00204	CbGeAlD
Trifluoperazine—Leukopenia—Etoposide—brain cancer	0.000126	0.00277	CcSEcCtD
Trifluoperazine—CALM3—brain—brain cancer	0.000125	0.00203	CbGeAlD
Trifluoperazine—DRD2—head—brain cancer	0.000125	0.00202	CbGeAlD
Trifluoperazine—Decreased appetite—Temozolomide—brain cancer	0.000125	0.00274	CcSEcCtD
Trifluoperazine—CALM2—central nervous system—brain cancer	0.000124	0.00201	CbGeAlD
Trifluoperazine—Fatigue—Temozolomide—brain cancer	0.000124	0.00272	CcSEcCtD
Trifluoperazine—CHRM2—brain—brain cancer	0.000123	0.002	CbGeAlD
Trifluoperazine—CALM1—central nervous system—brain cancer	0.000123	0.002	CbGeAlD
Trifluoperazine—HTR1A—cerebellum—brain cancer	0.000123	0.002	CbGeAlD
Trifluoperazine—Cough—Etoposide—brain cancer	0.000123	0.0027	CcSEcCtD
Trifluoperazine—Constipation—Temozolomide—brain cancer	0.000122	0.0027	CcSEcCtD
Trifluoperazine—Convulsion—Etoposide—brain cancer	0.000122	0.00268	CcSEcCtD
Trifluoperazine—Dizziness—Hydroxyurea—brain cancer	0.000121	0.00267	CcSEcCtD
Trifluoperazine—CALM2—cerebellum—brain cancer	0.000121	0.00196	CbGeAlD
Trifluoperazine—CALM1—cerebellum—brain cancer	0.000121	0.00195	CbGeAlD
Trifluoperazine—HTR2C—brain—brain cancer	0.000119	0.00193	CbGeAlD
Trifluoperazine—Body temperature increased—Carmustine—brain cancer	0.000117	0.00258	CcSEcCtD
Trifluoperazine—ADRA1A—central nervous system—brain cancer	0.000116	0.00188	CbGeAlD
Trifluoperazine—Rash—Hydroxyurea—brain cancer	0.000116	0.00255	CcSEcCtD
Trifluoperazine—Dermatitis—Hydroxyurea—brain cancer	0.000116	0.00254	CcSEcCtD
Trifluoperazine—Headache—Hydroxyurea—brain cancer	0.000115	0.00253	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Etoposide—brain cancer	0.000115	0.00252	CcSEcCtD
Trifluoperazine—DRD2—central nervous system—brain cancer	0.000114	0.00184	CbGeAlD
Trifluoperazine—Urticaria—Temozolomide—brain cancer	0.000114	0.00251	CcSEcCtD
Trifluoperazine—ADRA1A—cerebellum—brain cancer	0.000114	0.00184	CbGeAlD
Trifluoperazine—Body temperature increased—Temozolomide—brain cancer	0.000113	0.00249	CcSEcCtD
Trifluoperazine—SIGMAR1—brain—brain cancer	0.000112	0.00181	CbGeAlD
Trifluoperazine—DRD2—cerebellum—brain cancer	0.000111	0.0018	CbGeAlD
Trifluoperazine—Skin disorder—Etoposide—brain cancer	0.000111	0.00245	CcSEcCtD
Trifluoperazine—HTR2A—gonad—brain cancer	0.00011	0.00179	CbGeAlD
Trifluoperazine—Anorexia—Etoposide—brain cancer	0.000109	0.00241	CcSEcCtD
Trifluoperazine—Hypersensitivity—Carmustine—brain cancer	0.000109	0.00241	CcSEcCtD
Trifluoperazine—Nausea—Hydroxyurea—brain cancer	0.000109	0.0024	CcSEcCtD
Trifluoperazine—HTR2A—pituitary gland—brain cancer	0.000108	0.00174	CbGeAlD
Trifluoperazine—Hypotension—Etoposide—brain cancer	0.000107	0.00236	CcSEcCtD
Trifluoperazine—CYP1A2—endocrine gland—brain cancer	0.000107	0.00173	CbGeAlD
Trifluoperazine—Asthenia—Carmustine—brain cancer	0.000106	0.00234	CcSEcCtD
Trifluoperazine—Hypersensitivity—Temozolomide—brain cancer	0.000106	0.00232	CcSEcCtD
Trifluoperazine—HTR2A—medulla oblongata—brain cancer	0.000104	0.00168	CbGeAlD
Trifluoperazine—Asthenia—Temozolomide—brain cancer	0.000103	0.00226	CcSEcCtD
Trifluoperazine—Dyspnoea—Etoposide—brain cancer	0.000102	0.00225	CcSEcCtD
Trifluoperazine—Somnolence—Etoposide—brain cancer	0.000102	0.00224	CcSEcCtD
Trifluoperazine—Pruritus—Temozolomide—brain cancer	0.000101	0.00223	CcSEcCtD
Trifluoperazine—HTR1A—brain—brain cancer	0.0001	0.00162	CbGeAlD
Trifluoperazine—HRH1—endocrine gland—brain cancer	9.99e-05	0.00162	CbGeAlD
Trifluoperazine—Decreased appetite—Etoposide—brain cancer	9.96e-05	0.00219	CcSEcCtD
Trifluoperazine—Fatigue—Etoposide—brain cancer	9.88e-05	0.00218	CcSEcCtD
Trifluoperazine—HRH1—head—brain cancer	9.86e-05	0.0016	CbGeAlD
Trifluoperazine—CALM2—brain—brain cancer	9.84e-05	0.00159	CbGeAlD
Trifluoperazine—Dizziness—Carmustine—brain cancer	9.8e-05	0.00216	CcSEcCtD
Trifluoperazine—Constipation—Etoposide—brain cancer	9.8e-05	0.00216	CcSEcCtD
Trifluoperazine—CALM1—brain—brain cancer	9.8e-05	0.00159	CbGeAlD
Trifluoperazine—Thioridazine—CYP2C9—brain cancer	9.55e-05	0.224	CrCbGaD
Trifluoperazine—HTR2A—midbrain—brain cancer	9.5e-05	0.00154	CbGeAlD
Trifluoperazine—Dizziness—Temozolomide—brain cancer	9.47e-05	0.00209	CcSEcCtD
Trifluoperazine—Rash—Carmustine—brain cancer	9.35e-05	0.00206	CcSEcCtD
Trifluoperazine—Dermatitis—Carmustine—brain cancer	9.34e-05	0.00206	CcSEcCtD
Trifluoperazine—Headache—Carmustine—brain cancer	9.29e-05	0.00205	CcSEcCtD
Trifluoperazine—HTR2A—spinal cord—brain cancer	9.27e-05	0.0015	CbGeAlD
Trifluoperazine—ADRA1A—brain—brain cancer	9.23e-05	0.00149	CbGeAlD
Trifluoperazine—Urticaria—Etoposide—brain cancer	9.11e-05	0.00201	CcSEcCtD
Trifluoperazine—Body temperature increased—Etoposide—brain cancer	9.06e-05	0.002	CcSEcCtD
Trifluoperazine—DRD2—brain—brain cancer	9.05e-05	0.00146	CbGeAlD
Trifluoperazine—Rash—Temozolomide—brain cancer	9.03e-05	0.00199	CcSEcCtD
Trifluoperazine—Dermatitis—Temozolomide—brain cancer	9.02e-05	0.00199	CcSEcCtD
Trifluoperazine—HRH1—central nervous system—brain cancer	9e-05	0.00146	CbGeAlD
Trifluoperazine—Promethazine—CYP2C9—brain cancer	8.98e-05	0.211	CrCbGaD
Trifluoperazine—Headache—Temozolomide—brain cancer	8.97e-05	0.00198	CcSEcCtD
Trifluoperazine—Nausea—Carmustine—brain cancer	8.8e-05	0.00194	CcSEcCtD
Trifluoperazine—Perphenazine—CYP2C9—brain cancer	8.76e-05	0.206	CrCbGaD
Trifluoperazine—ABCB1—telencephalon—brain cancer	8.67e-05	0.0014	CbGeAlD
Trifluoperazine—Nausea—Temozolomide—brain cancer	8.51e-05	0.00187	CcSEcCtD
Trifluoperazine—Hypersensitivity—Etoposide—brain cancer	8.45e-05	0.00186	CcSEcCtD
Trifluoperazine—HTR2A—endocrine gland—brain cancer	8.34e-05	0.00135	CbGeAlD
Trifluoperazine—HTR2A—head—brain cancer	8.24e-05	0.00133	CbGeAlD
Trifluoperazine—Asthenia—Etoposide—brain cancer	8.22e-05	0.00181	CcSEcCtD
Trifluoperazine—Pruritus—Etoposide—brain cancer	8.11e-05	0.00179	CcSEcCtD
Trifluoperazine—Promazine—CYP2C9—brain cancer	7.9e-05	0.185	CrCbGaD
Trifluoperazine—Dizziness—Etoposide—brain cancer	7.58e-05	0.00167	CcSEcCtD
Trifluoperazine—HTR2A—central nervous system—brain cancer	7.52e-05	0.00122	CbGeAlD
Trifluoperazine—Clozapine—CYP2C9—brain cancer	7.39e-05	0.174	CrCbGaD
Trifluoperazine—HTR2A—cerebellum—brain cancer	7.35e-05	0.00119	CbGeAlD
Trifluoperazine—ABCB1—gonad—brain cancer	7.23e-05	0.00117	CbGeAlD
Trifluoperazine—Rash—Etoposide—brain cancer	7.23e-05	0.00159	CcSEcCtD
Trifluoperazine—Dermatitis—Etoposide—brain cancer	7.22e-05	0.00159	CcSEcCtD
Trifluoperazine—Headache—Etoposide—brain cancer	7.18e-05	0.00158	CcSEcCtD
Trifluoperazine—HRH1—brain—brain cancer	7.15e-05	0.00116	CbGeAlD
Trifluoperazine—ABCB1—pituitary gland—brain cancer	7.06e-05	0.00114	CbGeAlD
Trifluoperazine—ABCB1—medulla oblongata—brain cancer	6.81e-05	0.0011	CbGeAlD
Trifluoperazine—Nausea—Etoposide—brain cancer	6.81e-05	0.0015	CcSEcCtD
Trifluoperazine—ABCB1—midbrain—brain cancer	6.23e-05	0.00101	CbGeAlD
Trifluoperazine—ABCB1—spinal cord—brain cancer	6.07e-05	0.000983	CbGeAlD
Trifluoperazine—HTR2A—brain—brain cancer	5.97e-05	0.000966	CbGeAlD
Trifluoperazine—ABCB1—endocrine gland—brain cancer	5.47e-05	0.000885	CbGeAlD
Trifluoperazine—ABCB1—head—brain cancer	5.4e-05	0.000874	CbGeAlD
Trifluoperazine—ABCB1—central nervous system—brain cancer	4.93e-05	0.000797	CbGeAlD
Trifluoperazine—ABCB1—cerebellum—brain cancer	4.82e-05	0.000779	CbGeAlD
Trifluoperazine—ABCB1—brain—brain cancer	3.91e-05	0.000633	CbGeAlD
Trifluoperazine—HTR2C—Signaling by GPCR—IL2—brain cancer	4.34e-06	0.000136	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NOTCH2—brain cancer	4.34e-06	0.000136	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PIK3CG—brain cancer	4.3e-06	0.000135	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PIK3CG—brain cancer	4.3e-06	0.000135	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—HES1—brain cancer	4.29e-06	0.000135	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HES1—brain cancer	4.28e-06	0.000134	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.27e-06	0.000134	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IRS2—brain cancer	4.25e-06	0.000133	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—IL2—brain cancer	4.22e-06	0.000133	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HES1—brain cancer	4.21e-06	0.000132	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOTCH2—brain cancer	4.2e-06	0.000132	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOTCH2—brain cancer	4.2e-06	0.000132	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HES1—brain cancer	4.2e-06	0.000132	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—IL2—brain cancer	4.15e-06	0.00013	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PDGFRA—brain cancer	4.15e-06	0.00013	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IRS2—brain cancer	4.15e-06	0.00013	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ENO2—brain cancer	4.14e-06	0.00013	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—IL2—brain cancer	4.14e-06	0.00013	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VAV1—brain cancer	4.14e-06	0.00013	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IRS2—brain cancer	4.13e-06	0.00013	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IRS2—brain cancer	4.11e-06	0.000129	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IRS2—brain cancer	4.11e-06	0.000129	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	4.08e-06	0.000128	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—IL2—brain cancer	4.08e-06	0.000128	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PDGFRA—brain cancer	4.07e-06	0.000128	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	4.07e-06	0.000128	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SPP1—brain cancer	4.03e-06	0.000126	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	4.01e-06	0.000126	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VAV1—brain cancer	4e-06	0.000126	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VAV1—brain cancer	4e-06	0.000126	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	4e-06	0.000126	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SPP1—brain cancer	3.96e-06	0.000124	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SPP1—brain cancer	3.95e-06	0.000124	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SPP1—brain cancer	3.89e-06	0.000122	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SPP1—brain cancer	3.88e-06	0.000122	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—RELA—brain cancer	3.87e-06	0.000121	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—ERBB2—brain cancer	3.84e-06	0.000121	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL2—brain cancer	3.83e-06	0.00012	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL2—brain cancer	3.77e-06	0.000118	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL2—brain cancer	3.76e-06	0.000118	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—EGFR—brain cancer	3.75e-06	0.000118	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—APC—brain cancer	3.75e-06	0.000118	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL2—brain cancer	3.7e-06	0.000116	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL2—brain cancer	3.69e-06	0.000116	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	3.66e-06	0.000115	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—APC—brain cancer	3.66e-06	0.000115	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—APC—brain cancer	3.64e-06	0.000114	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	3.64e-06	0.000114	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IRS2—brain cancer	3.64e-06	0.000114	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—EGFR—brain cancer	3.63e-06	0.000114	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—EGFR—brain cancer	3.63e-06	0.000114	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—APC—brain cancer	3.63e-06	0.000114	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—APC—brain cancer	3.63e-06	0.000114	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—EGFR—brain cancer	3.61e-06	0.000113	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IRS2—brain cancer	3.58e-06	0.000113	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IRS2—brain cancer	3.58e-06	0.000112	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HES1—brain cancer	3.56e-06	0.000112	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IRS2—brain cancer	3.52e-06	0.00011	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IRS2—brain cancer	3.51e-06	0.00011	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TP53—brain cancer	3.5e-06	0.00011	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—EGFR—brain cancer	3.49e-06	0.00011	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—EGFR—brain cancer	3.49e-06	0.00011	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL2—brain cancer	3.48e-06	0.000109	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HES1—brain cancer	3.44e-06	0.000108	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HES1—brain cancer	3.44e-06	0.000108	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CCND1—brain cancer	3.39e-06	0.000107	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PDGFRA—brain cancer	3.39e-06	0.000106	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TP53—brain cancer	3.39e-06	0.000106	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TP53—brain cancer	3.39e-06	0.000106	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CTNNB1—brain cancer	3.36e-06	0.000106	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—EGFR—brain cancer	3.34e-06	0.000105	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—EGFR—brain cancer	3.32e-06	0.000104	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SPP1—brain cancer	3.29e-06	0.000103	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PDGFRA—brain cancer	3.28e-06	0.000103	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PDGFRA—brain cancer	3.28e-06	0.000103	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—APC—brain cancer	3.22e-06	0.000101	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PIK3CG—brain cancer	3.22e-06	0.000101	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SPP1—brain cancer	3.18e-06	9.99e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SPP1—brain cancer	3.18e-06	9.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—RELA—brain cancer	3.17e-06	9.97e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—APC—brain cancer	3.16e-06	9.94e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	3.16e-06	9.94e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CG—brain cancer	3.16e-06	9.92e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—APC—brain cancer	3.16e-06	9.92e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—ERBB2—brain cancer	3.16e-06	9.91e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CG—brain cancer	3.14e-06	9.87e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL2—brain cancer	3.13e-06	9.83e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	3.11e-06	9.76e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—APC—brain cancer	3.11e-06	9.76e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—APC—brain cancer	3.1e-06	9.73e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	3.1e-06	9.73e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—RELA—brain cancer	3.07e-06	9.65e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—RELA—brain cancer	3.07e-06	9.65e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—ERBB2—brain cancer	3.05e-06	9.58e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—ERBB2—brain cancer	3.05e-06	9.58e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CG—brain cancer	3.04e-06	9.54e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CG—brain cancer	3.04e-06	9.54e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL2—brain cancer	3.03e-06	9.51e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL2—brain cancer	3.03e-06	9.51e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IRS2—brain cancer	2.97e-06	9.34e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—VEGFA—brain cancer	2.96e-06	9.3e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—STAT3—brain cancer	2.93e-06	9.2e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—EGFR—brain cancer	2.93e-06	9.2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—ERBB2—brain cancer	2.91e-06	9.15e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—EGFR—brain cancer	2.88e-06	9.06e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IRS2—brain cancer	2.88e-06	9.04e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IRS2—brain cancer	2.88e-06	9.04e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—EGFR—brain cancer	2.88e-06	9.04e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—RELA—brain cancer	2.86e-06	8.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL2—brain cancer	2.86e-06	8.98e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—RELA—brain cancer	2.85e-06	8.94e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—ERBB2—brain cancer	2.84e-06	8.93e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—EGFR—brain cancer	2.83e-06	8.89e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—ERBB2—brain cancer	2.83e-06	8.89e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	2.82e-06	8.87e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—ERBB2—brain cancer	2.82e-06	8.85e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—ERBB2—brain cancer	2.82e-06	8.85e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL2—brain cancer	2.77e-06	8.69e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL2—brain cancer	2.77e-06	8.69e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CTNNB1—brain cancer	2.76e-06	8.67e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MYC—brain cancer	2.72e-06	8.55e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CTNNB1—brain cancer	2.67e-06	8.39e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CTNNB1—brain cancer	2.67e-06	8.39e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—EGFR—brain cancer	2.66e-06	8.36e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CG—brain cancer	2.63e-06	8.25e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—APC—brain cancer	2.63e-06	8.25e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL2—brain cancer	2.58e-06	8.1e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL2—brain cancer	2.56e-06	8.05e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CTNNB1—brain cancer	2.55e-06	8e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CG—brain cancer	2.54e-06	7.98e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CG—brain cancer	2.54e-06	7.98e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—APC—brain cancer	2.54e-06	7.98e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—APC—brain cancer	2.54e-06	7.98e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—RELA—brain cancer	2.51e-06	7.89e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CCND1—brain cancer	2.51e-06	7.89e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CCND1—brain cancer	2.5e-06	7.85e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—ERBB2—brain cancer	2.5e-06	7.84e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	2.49e-06	7.82e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	2.48e-06	7.78e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—RELA—brain cancer	2.47e-06	7.77e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—RELA—brain cancer	2.47e-06	7.75e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CTNNB1—brain cancer	2.47e-06	7.74e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CTNNB1—brain cancer	2.47e-06	7.74e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—ERBB2—brain cancer	2.46e-06	7.72e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—ERBB2—brain cancer	2.45e-06	7.7e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—RELA—brain cancer	2.43e-06	7.63e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—RELA—brain cancer	2.42e-06	7.6e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—ERBB2—brain cancer	2.41e-06	7.58e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—STAT3—brain cancer	2.41e-06	7.56e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	2.41e-06	7.56e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—EGFR—brain cancer	2.39e-06	7.52e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CG—brain cancer	2.38e-06	7.48e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—STAT3—brain cancer	2.33e-06	7.31e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—STAT3—brain cancer	2.33e-06	7.31e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—EGFR—brain cancer	2.32e-06	7.27e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—EGFR—brain cancer	2.32e-06	7.27e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL2—brain cancer	2.26e-06	7.11e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—brain cancer	2.24e-06	7.02e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL2—brain cancer	2.23e-06	6.99e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL2—brain cancer	2.22e-06	6.98e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—STAT3—brain cancer	2.22e-06	6.98e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCND1—brain cancer	2.21e-06	6.93e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—brain cancer	2.19e-06	6.88e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EGFR—brain cancer	2.19e-06	6.87e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL2—brain cancer	2.19e-06	6.87e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CTNNB1—brain cancer	2.19e-06	6.86e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL2—brain cancer	2.18e-06	6.85e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—brain cancer	2.18e-06	6.85e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCND1—brain cancer	2.17e-06	6.82e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—STAT3—brain cancer	2.17e-06	6.81e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCND1—brain cancer	2.17e-06	6.8e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—STAT3—brain cancer	2.16e-06	6.78e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	2.15e-06	6.75e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—STAT3—brain cancer	2.15e-06	6.75e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—STAT3—brain cancer	2.15e-06	6.75e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CTNNB1—brain cancer	2.15e-06	6.74e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCND1—brain cancer	2.13e-06	6.69e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCND1—brain cancer	2.13e-06	6.68e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EGFR—brain cancer	2.12e-06	6.64e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EGFR—brain cancer	2.12e-06	6.64e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	2.11e-06	6.63e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	2.11e-06	6.61e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MYC—brain cancer	2.06e-06	6.48e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—RELA—brain cancer	2.05e-06	6.45e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ERBB2—brain cancer	2.04e-06	6.41e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EGFR—brain cancer	2.02e-06	6.34e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MYC—brain cancer	2.02e-06	6.33e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MYC—brain cancer	2.01e-06	6.3e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MYC—brain cancer	2e-06	6.27e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MYC—brain cancer	2e-06	6.27e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—RELA—brain cancer	1.99e-06	6.24e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—RELA—brain cancer	1.99e-06	6.24e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ERBB2—brain cancer	1.97e-06	6.2e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ERBB2—brain cancer	1.97e-06	6.2e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EGFR—brain cancer	1.97e-06	6.19e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EGFR—brain cancer	1.96e-06	6.16e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EGFR—brain cancer	1.95e-06	6.13e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EGFR—brain cancer	1.95e-06	6.13e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—brain cancer	1.92e-06	6.04e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—STAT3—brain cancer	1.9e-06	5.98e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CG—brain cancer	1.9e-06	5.97e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—brain cancer	1.89e-06	5.94e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—brain cancer	1.89e-06	5.93e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—STAT3—brain cancer	1.87e-06	5.89e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—STAT3—brain cancer	1.87e-06	5.87e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—brain cancer	1.86e-06	5.84e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	1.85e-06	5.82e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2—brain cancer	1.85e-06	5.81e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—STAT3—brain cancer	1.84e-06	5.78e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—STAT3—brain cancer	1.84e-06	5.76e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCND1—brain cancer	1.8e-06	5.66e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2—brain cancer	1.79e-06	5.62e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2—brain cancer	1.79e-06	5.62e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CTNNB1—brain cancer	1.78e-06	5.6e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MYC—brain cancer	1.77e-06	5.56e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCND1—brain cancer	1.74e-06	5.48e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCND1—brain cancer	1.74e-06	5.48e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MYC—brain cancer	1.74e-06	5.47e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MYC—brain cancer	1.74e-06	5.46e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EGFR—brain cancer	1.73e-06	5.44e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CTNNB1—brain cancer	1.73e-06	5.42e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CTNNB1—brain cancer	1.73e-06	5.42e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MYC—brain cancer	1.71e-06	5.37e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MYC—brain cancer	1.71e-06	5.35e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EGFR—brain cancer	1.7e-06	5.35e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EGFR—brain cancer	1.7e-06	5.34e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EGFR—brain cancer	1.67e-06	5.25e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EGFR—brain cancer	1.67e-06	5.24e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—brain cancer	1.66e-06	5.2e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—brain cancer	1.65e-06	5.17e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—brain cancer	1.57e-06	4.93e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—STAT3—brain cancer	1.56e-06	4.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—brain cancer	1.52e-06	4.77e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—brain cancer	1.52e-06	4.77e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—STAT3—brain cancer	1.5e-06	4.73e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—STAT3—brain cancer	1.5e-06	4.73e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—brain cancer	1.45e-06	4.56e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MYC—brain cancer	1.45e-06	4.54e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—brain cancer	1.43e-06	4.49e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—brain cancer	1.43e-06	4.48e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EGFR—brain cancer	1.41e-06	4.44e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—brain cancer	1.4e-06	4.41e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—brain cancer	1.4e-06	4.4e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MYC—brain cancer	1.4e-06	4.39e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MYC—brain cancer	1.4e-06	4.39e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EGFR—brain cancer	1.37e-06	4.3e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EGFR—brain cancer	1.37e-06	4.3e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—brain cancer	1.19e-06	3.73e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—brain cancer	1.15e-06	3.61e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—brain cancer	1.15e-06	3.61e-05	CbGpPWpGaD
